Browse > Article

Amperometric Determination of Anthracycline Antibiotics with the Mercury Film Thin Layer Flow Cell  

Kim, Kyung Eun (Department of Chemistry, Sangmyung University)
Hahn, Younghee (Department of Chemistry, Sangmyung University)
Publication Information
Analytical Science and Technology / v.17, no.6, 2004 , pp. 470-475 More about this Journal
Abstract
The mercury film thin layer flow cell (MFTLFC) which yielded the highest sensitivity for the electrochemical reduction of doxorubicin was constructed by coating the glassy carbon working electrode (GCE; $A=0.208cm^2$) with $5{\mu}L$ of HgO coating solution (0.5% HgO + 0.25% polystyrene/cyclohexanone) and subsequently followed by applying a potential of -0.40 V for 300 sec in the flow stream of an acetate buffer of pH 4.5. The voltammogram of doxorubicin reached the diffusion current plateau at -0.53 V vs. a Ag/AgCl (3 M NaCl) in the MFTLFC. The diffusion current (Id) of doxorubicin at the MFTLFC was 1.7 times greater than the Id obtained at the TLFC employing a bare glassy carbon working electrode. When the peak areas (electric charge) were plotted vs. concentrations of standard anthracyclines, the calibration factors of doxorubicin and daunorubicin were $1.12{\times}10^8{\mu}C/M$ (coefficient of determination; $R^2$: 0.969) and $0.98{\times}10^8{\mu}C/M$> ($R^2$: 0.999), respectively in the concentration range between $1.0{\times}10^{-8}M$ and $1.0{\times}10^{-6}M$.
Keywords
mercury film thin layer flow cell; doxorubicin; daunorubicin; flow injection analysis;
Citations & Related Records
연도 인용수 순위
  • Reference
1 P. W. Buehler, S. J. Robles, G. R. Adami, R. Gajee and A. Negrusz, Chromatographia, 49, 557-561(1999).
2 R. Ricciarello, S. Pichini, R. Pacifici, I. Altieri, M. Pellegrini, A. Fattorossi and P. Zuccaro, J. Chromatogr. B, 707, 219-225(1998).
3 Q. Hu, L. Zhang, T. Zhou and Y. Fang, Anal. Chim. Acta, 416, 15-19(2000).
4 Y. Hahn and J.-Y. Yoo, J. Kor. Chem. Soc., 41, 180-185(1997).
5 R. G.-M. Carra, A. Sάnchez-Misiego and A. Zirino, Anal. Chem., 67, 4484-4486(1995).
6 F. Lachâtre, P. Marquet, S. Ragot, J. M. Gaulier, P. Cardot and J. L. Dupuy, J. Chromatogr. B, 738, 281-291(2000).
7 British Pharmacopoeia Commission, 'British Pharmacopoeia', 492, 594, The Stationery Office, London, England, 2000.
8 한국 식품 의약품 안전청, '항생물질의약품기준', 315-320, 약업신문사, 한국, 2000.
9 European Pharmacopoeia Commission, 'European Pharmacopoeia', 706, 784, Council of Europe, Strasbourg, 1997.
10 L. Álvarez-Cedrón, M. L. Sayalero and J. M. Lanao, J. Chromatogr. B, 721, 271-278(1999).
11 Y. Hahn and H. Y. Lee, Arch. Pharm. Res., 27, 31-34(2004).
12 H. P. Wu, Anal. Chem., 66, 3151-3157(1994).
13 United States Pharmacopeial Convention, 'U. S. Pharmacopeia & National Formulary', 498, 606, National Publishing, Philadelphia, PA U.S.A., 2000.
14 T. Lee, K.-C. Chung and J. Park, Electroanalysis, 14, 833-838(2002).